NCT00593866View on ClinicalTrials.gov

Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2012

Study Completion Date

October 31, 2014

Conditions
Pancreatic Cancer
Interventions
RADIATION

INTENSITY MODULATED RADIOTHERAPY

Five fractions weekly, fraction size determined by dose level

DRUG

Gemcitabine

1000mg/m2 will be infused over 100 minutes on days 1, 8, 22 and 29 of the radiation treatment

Trial Locations (2)

60612-3833

Rush University Medical Center, Chicago

48109-5010

University Of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Rush University Medical Center

OTHER

lead

University of Michigan Rogel Cancer Center

OTHER

NCT00593866 - Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter